Cocktail-Solvent Screening to Enhance Solubility, Increase Crystal Yield, and Induce Polymorphs - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Cocktail-Solvent Screening to Enhance Solubility, Increase Crystal Yield, and Induce Polymorphs
The authors propose extending initial solvent screening for a single-solvent system to the cocktail solvent screening of binary and ternary solvent mixtures.

Pharmaceutical Technology
Volume 32, Issue 1

11. T. Lee and M.S. Lin, "Sublimation Point Depression of Tris(8-hydroxyquinoline) aluminum (III) (Alq3) by Crystal Engineering," Cryst. Growth Des. 7 (9), 1803–1810 (2007).

12. Y. Kawashima, M. Okumura and H. Takenaka, "Spherical Crystallization: Direct Spherical Agglomeration of Salicylic Acid Crystals During Crystallization," Science 216 (4550), 1127–1128 (1982).

13. R.A. Granberg and .C. Rasmuson, "Crystal Growth Rates of Paracetamol in Mixtures of Water + Acetone + Toluene," AIChE Journal 51 (9), 2441–2456 (2005).

14. M.L. Peterson et al., "Iterative High-Throughput Polymorphism Studies on Acetaminophen and an Experimentally Derived Structure for Form III," J. Am. Chem. Soc. 124 (37), 10958–10959 (2002).

15. J.E. Anderson et al., "Determination of the Onset of Crystallization of N1-2-(thiazolyl)sulfanilamide (sulfathiazole) by UV–Vis and Calorimetry Using an Automated Reaction Platform; Subsequent Characterization of Polymorphic Forms Using Dispersive Raman Spectroscopy," Spectrochimica Acta Part A 57 (9), 1793–1808 (2001).

16. S. Khoshkhoo and J. Anwar, "Crystallization of Polymorphs: the Effect of Solvent," J. Phys. D: Appl. Phys. 26 (8B), B90–B93 (1993).

17. J. Anwar, S.E. Tarling, and P. Barnes, "Polymorphism of Sulfathiazole," J. Pharm Sci. 78 (4), 337–342 (1989).

18. D.C. Grove and G. Keenan, "The Dimorphism of Sulfathiazole," J. Am. Chem. Soc. 63 (1), 97–99 (1941).

19. A.L. Bingham et al., "Over One Hundred Solvates of Sulfathiazole," Chem. Commun. (7), 603–604 (2001).

20. E. Tedesco, D. Giron, and S. Pfeffer, "Crystal Structure Elucidation and Morphology Study of Pharmaceuticals in Development," Cryst. Eng. Comm. 4 (67), 393–400 (2002).

21. N. Blagden and R.J. Davey, "Review: Polymorph Selection—Challenges for the Future?" Cryst. Growth Des. 3 (6), 873–885 (2003).

22. D. Winn and M.F. Doherty, "Modeling Crystal Shapes of Organic Materials Grown from Solution," AIChE J. 46 (7), 1348–1367 (2000).

23. S. Byrn, K. Morris, and S. Comella, "Reducing Time to Market with a Science-Based Product," Pharm. Technol. Outsourcing Resources for the Pharmaceutical Industry supplement, 46–56 (2005).

24. T. Lee, C.S. Kuo, and Y.H. Chen, "Solubility, Polymorphism, Crystallinity, and Crystal Acetaminophen and Ibuprofen by Initial Solvent Screening," Pharm. Technol. 30 (10), 72–92 (2006).

25. N.G. Anderson, Practical Process Research and Development , (Academic Press, New York, 2000), pp. 81–111.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here